| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |